INTRODUCTION
Polymorphisms in genes associated with one-carbon folate metabolism have been proposed as risk factors for a variety of disorders, including birth defects, pregnancy complications, heart disease and cancer (1) . The best-characterized polymorphism in this group is the MTHFR 677C . T variant which increases the risk of neural tube defects (NTDs) (2, 3) , cardiovascular disease (4) and other disorders (5) . Low folate intake has also been linked to these disorders, and may modulate the effects of these genetic variants on disease risk (6 -9) . Polymorphisms in folate-dependent enzymes and low dietary folate can be deleterious because one-carbon transfer reactions are required for the biosynthesis of nucleotides and amino acids, and the detoxification of homocysteine by remethylation to methionine, with subsequent generation of S-adenosylmethionine (SAM) for methylation reactions ( Fig. 1) (10) . MTHFD1 p.R653Q (1958G.A; rs2236225) is a singlenucleotide polymorphism (SNP) that results in an amino acid substitution in the synthetase domain of a trifunctional enzyme involved in folate inter-conversion (11) . It is quite common; roughly 20% of Caucasian populations are homozygous for the Q allele (12) (13) (14) (15) . This variant is a risk factor for NTD in Irish mothers (12, 16, 17) and may increase NTD risk in Italian and American children (14, 18, 19) . It was not associated with NTD risk in studies of the Dutch population (11, 20) . NTD risk associated with this variant may be influenced by folate intake or by other variants (19, 21) . MTHFD1 p.R653Q may also increase the risk of intrauterine growth restriction (22) , and has been linked to increased pregnancy losses in Irish, but not Romanian, studies (23) (24) (25) . In a pre-fortification Canadian cohort of children with congenital heart defects (CHDs), we found that the QQ genotype in children increased the risk for specific types of heart defects (aortic stenosis and Tetralogy of Fallot) (13) . However, no association between this variant and heart defects was reported in studies examining other populations or heart defect subtypes (18, 26, 27) .
MTHFD1 is a cytoplasmic enzyme with 5,10-methylenetetrahydrofolate (methyleneTHF) dehydrogenase, 5,10-methenyltetrahydrofolate (methenylTHF) cyclohydrolase and 10-formyltetrahydrofolate (formylTHF) synthetase activities (Fig. 1) . The enzyme consists of two functionally independent domains: the dehydrogenase -cyclohydrolase (DC) domain, which catalyses the conversion of one-carbon substituted folates between the 5,10-methyleneTHF, 5,10-methenylTHF and 10-formylTHF oxidation states, and the synthetase domain, which produces formylTHF from formate and THF (28) . We have shown that the p.R653Q substitution reduces the stability of the synthetase domain, and alters the metabolic activity of MTHFD1 (13) . Formate incorporation into DNA in cells expressing the MTHFD1 cDNA containing the p.R653Q mutation was reduced 26% relative to the wild-type cDNA. This result indicates that purine synthesis is disrupted by this SNP, because synthesis of a purine requires two molecules of 10-formylTHF, the product of the synthetase reaction (13) . The instability of the p.R653Q synthetase domain was rescued by saturating amounts of folate pentaglutamate, suggesting that folate intake may modulate the impact of the variant (13) .
During embryonic development, MTHFD1 synthetase uses formate generated from serine and glycine in the mitochondria to produce formylTHF ( Fig. 1) (10) . This formylTHF is used in de novo purine synthesis in the cytoplasm or converted to methyleneTHF. This methyleneTHF could be used to produce dTMP, but appears to primarily be reduced to 5-methylTHF and used to remethylate homocysteine to methionine (10, 29) . MethyleneTHF is also produced from serine and THF by SHMT1; however, it appears to be primarily produced in the nucleus during DNA replication, and therefore may not be a significant source of carbon for conversion to formylTHF for de novo purine synthesis (30) . Consequently, the impact of genetic variants in the MTHFD1-synthetase domain may be greatest during pregnancy and embryogenesis when the demand for de novo purine synthesis is high (31) .
We have generated a novel mouse model of MTHFD1-synthetase deficiency to examine the biochemical and phenotypical consequences of this deficiency in vivo. In these mice, the synthetase activity of MTHFD1 is reduced, without affecting the function of the DC domain. Mice with no synthetase activity are not viable. Heterozygosity for synthetase deficiency is associated with reduced purine synthesis and leads to neutropenia during pregnancy and developmental defects in embryos.
RESULTS

Generation of mice lacking MTHFD1 10-formyltetrahydrofolate synthetase activity
To assess the biochemical and phenotypical consequences of a loss of 10-formylTHF synthetase activity, we generated a mouse lacking only the synthetase activity of the trifunctional MTHFD1 protein, by mutating a critical amino acid in the synthetase domain. The heterozygous mutant mouse would be expected to be a good model for individuals homozygous for the MTHFD1 p.R653Q variant, which reduces metabolic activity in cells by 26%, or for any other of the numerous reported SNPs in the synthetase domain that may affect its function.
p.K386 is a lysine residue in the formylTHF synthetase active site of MTHFD1 homologous to lysine 74 of Moorella thermoaceticum formylTHF synthetase which is required for ATP binding (32) . Mutation of p.K386 to glutamate completely abrogates formylTHF synthetase activity of murine MTHFD1 (33) . p.K386E was introduced into the Mthfd1 gene by site-directed mutagenesis within a targeting vector used to generate knock-in ES cell lines ( Fig. 2A) . The targeted gene is referred to as Mthfd1-synthetase (Mthfd1S) to indicate that only the formylTHF synthetase activity is disrupted.
Germline transmission was established from two chimeras from separate Cre-recombinant cell lines (EH5 B5 and EH5 D1). Proper targeting and recombination in the parent cell lines and germline mice were verified by Southern blot and PCR ( Fig. 2B and C) . No substantive difference in phenotype between the EH5 B5 and EH5 D1 derived mouse strains was observed.
Knock-in of p.K386E mutation disrupts synthetase activity leaving dehydrogenase activity and MTHFD1 expression intact 10-FormylTHF synthetase and 5,10-methyleneTHF dehydrogenase activities were measured in liver extracts from 3-month-old male Mthfd1S +/+ and Mthfd1S +/-mice [N2 (two generations backcrossed), four per group]. Synthetase activity was reduced by 60% in the Mthfd1S +/-mice (P , 0.0001, t-test), whereas dehydrogenase activity did not change (Fig. 3A) . The multifunctionality of MTHFD1 allows the dehydrogenase activity to be used as an internal control for enzyme activity; the synthetase/dehydrogenase ratio in the Mthfd1S +/-extracts decreased by 57% relative to the wild-type (P , 0.0001, t-test). The cyclohydrolase activity of MTHFD1 was not measured. However, as the dehydrogenase and cyclohydrolase activities share an active site (34) , it is unlikely that cyclohydrolase activity is affected by the p.K386E mutation. MTHFD1 expression was measured by western blotting of liver extracts from 2-month-old male Mthfd1S +/+ and Mthfd1S +/-mice [N5 (five generations backcrossed), five per group] and normalized to the GAPDH loading control (Fig. 3B ). There was no significant difference between the expression of wild-type and mutant MTHFD1 (Mthfd1S +/+ : 1.31 + 0.38, Mthfd1S +/-: 1.11 + 0.15, P ¼ 0.30, t-test). Therefore the knock-in successfully reduces only the synthetase activity of MTHFD1 without disrupting its expression or the other activities in the trifunctional enzyme.
Mthfd1S
-/-mice are not viable; Mthfd1S 1/-mice appear to be healthy and fertile
Heterozygous crosses were performed after two generations of backcrossing onto the C57Bl/6N background (N2) to determine whether Mthfd1S -/-mice were viable. Sixty-eight pups (12 litters) from five mating pairs were genotyped (average litter size + SEM: 5.7 + 0.7); no Mthfd1S -/-pups were observed ( Table 1) . The observed genotype distribution differed significantly from the expected Mendelian inheritance by chisquare analysis (P , 0.0001), unless it was assumed that Mthfd1S -/-is embryonic lethal (P ¼ 0.95). Sex distribution of the pups did not differ from expected ratios by chi-square.
After five generations of backcrossing onto C57Bl/6N (N5), five additional pairs of Mthfd1S +/-mice were intercrossed and progeny genotyped (5 litters, 29 mice, average litter size + SEM: 5.8 + 1.0). No Mthfd1S -/-pups were observed in these litters, and genotype distribution, by chi-square analysis, was consistent with embryonic lethality. Pups were examined and weighed at weaning (10 days), and again at 1-week intervals until 7 weeks of age (n ¼ 6 per sex/genotype group, except female Mthfd1S +/-, n ¼ 11). Mthfd1S +/-mice appeared to be healthy and exhibited no significant differences in growth or body weight when compared with Mthfd1S +/+ during this period (data not shown).
Eight to 18-week-old males (n ¼ 8 Mthfd1S +/+ , 6 Mthfd1S +/-), and 11 to 20-week-old females (n ¼ 8 Mthfd1S
+/+ , 6 Mthfd1S +/-) were examined for body weight, organ (liver and spleen) weights and complete blood counts (CBC, males: n ¼ 4 Figure 1 . One-carbon folate metabolism. The enzymes in this pathway generate one-carbon substituted folates, inter-convert their oxidation states and use them for nucleotide synthesis and methylation reactions. MethyleneTHF dehydrogenase (D), methenylTHF cyclohydrolase (C) and formylTHF synthetase (S) activities are found in the cytoplasm in one trifunctional protein, MTHFD1, which has two functionally independent domains: DC and synthetase. The human R653Q variant is located in the synthetase domain (marked with asterisk). Serine donates one-carbon units to THF in the mitochondria (indicated by oval) to make methyleneTHF which is oxidized to formylTHF by MTHFD2 (embryos and transformed cells) or MTHFD2L (older embryos and adult cells). MTHFD1L uses this formylTHF to produce formate that exits the mitochondria and is used to make formylTHF by the MTHFD1 synthetase in the cytoplasm. FormylTHF is used as the one-carbon donor for 2 of the 10 reactions involved in de novo purine synthesis (GAR transformylase and AICAR transformylase), or reduced to methyleneTHF by the MTHFD1 DC domain. MethyleneTHF is used as a one-carbon donor in thymidylate synthesis, or reduced to methylTHF by MTHFR to be used as a one-carbon donor for the methylation cycle. MethyleneTHF is also produced from serine and THF by SHMT1 in the nucleus or cytoplasm depending on the stage of the cell cycle.
per group, females: n ¼ 6-8 per group). In males, there was no significant effect of genotype on body weight. In females, body weight was significantly higher in the heterozygous mice (23.8 + 0.6 versus 21.2 + 0.8 g, P , 0.05, t-test). There were no differences due to genotype for organ weights (as % body weight) or for CBC in either males or females.
Distribution of one-carbon folates is altered by MTHFD1-synthetase deficiency
To determine whether MTHFD1-synthetase deficiency affected the metabolism of one-carbon substituted folates, plasma folates were measured in 8-week-old males (n ¼ 4 per genotype) (Fig. 4 ). There were no significant differences in the absolute values of unsubstituted and one-carbon substituted folates in plasma; however, the proportion of 10-formylTHF (formylTHF as % total folates) was significantly decreased in Mthfd1S +/-mice (P , 0.05, t-test).
Methionine and choline metabolites in males and females are unaffected by MTHFD1-synthetase deficiency MTHFD1 may be required to supply the majority of one-carbon units used in the methylation cycle (29) . Therefore, synthetase deficiency could alter the levels of methylation cycle intermediates such as methionine (Fig. 1) . Synthetase deficiency could also increase reliance on the choline metabolite betaine, which can also supply one-carbon units for methylation, via BHMT (Fig. 1) , and potentially affect choline metabolism (35) (36) (37) . We assessed methionine and choline metabolites in plasma (for comparison with human data) and in liver (a major site of one-carbon folate metabolism with high levels of MTHFD1 expression) from these mice to determine whether the methylation cycle or choline metabolism was affected by synthetase deficiency.
Methionine and related metabolites [SAM, S-adenosylhomocysteine (SAH), methionine, cystathionine, betaine and choline in plasma and liver, and total homocysteine in plasma] were measured in plasma samples from 8-week-old males (n ¼ 4 per genotype) and in plasma and liver samples from 11-to 20-week-old females (n ¼ 8 Mthfd1S
). Methionine metabolite levels were not affected by Mthfd1S genotype (data not shown).
Choline and related metabolites [dimethylglycine (DMG), betaine, glycerophosphocholine (GPC), phosphocholine, phosphatidylcholine, sphingomyelin and lysophosphatidylcholine) were measured in liver samples from 8-to 18-week-old males (n ¼ 8 Mthfd1S
+/+ , 6 Mthfd1S +/-), and in 11-to 20-week-old females (n ¼ 8 Mthfd1S
). MTHFD1-synthetase deficiency did not significantly affect the levels of these metabolites in liver in males or females (data not shown).
Mthfd1S
-/-embryos are grossly abnormal and are not viable past E10.5
Thirteen litters from Mthfd1S
+/-parents were examined at 10.5 days gestation (E10.5), and expected numbers of embryos of all three genotypes were observed. Mthfd1S -/-embryos were severely delayed and abnormal, yet apparently viable because beating hearts were observed ( Fig. 5B and C) . The majority of Mthfd1S +/+ and Mthfd1S +/-E10.5 embryos (Fig. 5A ) were turned, had completed neural tube closure and formation of the lens plate, otic vesicle, fore and hind limb buds, and normal development of the caudal region. In contrast, the Mthfd1S -/-embryos ( Fig. 5B and C) were much smaller than their littermates, typically less than one-third the length of a wild-type or Mthfd1S +/-embryo, had few or no visible somites, and abnormal neural tube closure. Where the neural folds were closed, the neural tube had an unusual ruffled or kinked appearance (indicated by the arrow in Fig. 5C ), similar to the wavy neural tube reported in Mthfd1L z/z embryos (38) . The open head folds observed in the null embryos are likely to be an effect of their overall developmental delay, but they could reflect a defect in neural tube closure. The Mthfd1S -/-embryos resembled E8.5 embryos with 4 -12 pairs of somites, however, compared with normal E8.5, hearts of the Mthfd1S -/-embryos appeared to be larger and abnormal, and the tail bud was smaller and abnormal in shape (Fig. 5C ). A few Mthfd1S -/-embryos (n ¼ 3 of 33) appeared to be more advanced in development than most null embryos (with formation of the otic vesicle and partial closure of head folds), whereas others were further delayed or resorbing
-/-embryos were observed later in gestation (data not shown).
Dissection of litters from Mthfd1S +/-crosses at E7.5 (n ¼ 3) and E8.5 (n ¼ 1) indicated that Mthfd1S -/-embryos could be clearly distinguished from wild-type and Mthfd1S +/-littermates at these early stages. At E7.5, the Mthfd1S -/-embryos were smaller and had no apparent primitive streak or allantois formation ( Fig. 5D ; Supplementary Material, Fig. S1 ). By E8.5, the primitive streak and allantois were visible in an Mthfd1S -/-embryo, whereas normal littermates had well-developed headfolds and chorioallantoic attachment (not shown).
Maternal synthetase deficiency may increase the rate of developmental defects
Mthfd1S
+/+ (n ¼ 11) and Mthfd1S +/-(n ¼ 13) females were mated with Mthfd1S +/-males and sacrificed at E10.5 to examine embryos for developmental defects ( Table 2 ). This time point was selected to examine the embryos for defects immediately following neural tube closure, and to allow the examination of Mthfd1S -/-embryos, which are not viable after E10.5. Synthetase deficiency did not appear to affect maternal fertility. Average number of implants per litter, average number of egg releases per mother and embryonic loss (total resorptions/total implantation sites) were not significantly affected by maternal genotype.
Crown-rump length and somite number of embryos were not significantly affected by maternal synthetase deficiency (Table 2) . Similarly, although 5 -8% of embryos had developmental delays (.1 day), the incidence of delay was not significantly influenced by maternal genotype.
Developmental anomalies were observed in eight embryos (Table 2 ; Supplementary Material, Fig. S2 ); seven of these were from Mthfd1S +/-mothers. Defects included turning defects (caudal torque), craniofacial malformation (asymmetric underdevelopment of the telencephalic vesicle), and abnormal tail and limb bud development. All of these embryos showed signs of developmental delay, except for one wild-type embryo with caudal torque that appeared to be otherwise normal. The effect of maternal synthetase deficiency on the (A) FormylTHF synthetase and methyleneTHF dehydrogenase assays of liver extract from male wild-type and heterozygous mice (n ¼ 4, activity expressed as units per mg protein). The dehydrogenase activity of MTHFD1 remained constant, while the synthetase activity decreased by 60% ( * * * P , 0.0001, t test). (B) Western blot of MTHFD1 and GAPDH in liver extracts from male wild-type and heterozygous mice; there was no significant difference in MTHFD1 expression between wild-type and heterozygous mice (Mthfd1S
-test). Mthfd1S
-/-mice were not assayed as none survived to birth. incidence of defects was borderline significant (average % defects/litter P ¼ 0.052, t-test corrected for unequal variance; P ¼ 0.065 by Fisher's exact test for number of embryos with defects). We also assessed whether the embryonic genotype could contribute to developmental anomalies (Table 3) . Embryonic genotype distributions at this time point conformed to Mendelian ratios by chi-square analysis. When examined within maternal genotype groups, there was no significant difference by t-test between Mthfd1S
+/+ and Mthfd1S +/-embryos for the aforementioned parameters.
MTHFD1-synthetase deficiency alters hepatic one-carbon folate distribution and MTHFR activity in pregnant females
Although there were no differences in choline and methionine metabolites between genotype groups in males or non-pregnant females, as mentioned above, we also measured these parameters in pregnant females to determine whether changes in methylation intermediates in pregnancy could contribute to the increase in embryonic defects in Mthfd1S +/-mothers. There were no significant differences in choline or methionine metabolites in plasma or liver of pregnant females (n ¼ 11
Mthfd1S
+/+ and 13 -15 Mthfd1S +/-, data not shown). We measured the major circulatory form of folate, methylTHF, in plasma as well as the distribution of liver folates in pregnant mice to determine whether changes in maternal folate derivatives could contribute to the incidence of developmental defects in embryos. There were no differences in plasma methylTHF between genotype groups (n ¼ 11
+/+ and 15 Mthfd1S
, data not shown). However, significant changes in liver folate distributions were observed in pregnant mice (n ¼ 4 per genotype, Fig. 6 ). The proportions of dihydrofolate (DHF) (P , 0.005, t-test), THF (borderline significant, P ¼ 0.066, t-test) and formylTHF (near significant, P ¼ 0.0506, t-test) were decreased in Mthfd1S +/-mice. In contrast, the percentage of methylTHF was significantly increased (P , 0.05, t-test).
We assayed MTHFR in liver of pregnant females (n ¼ 5 per group) to determine whether increased activity could explain the increase in methylTHF. There was a borderline significant increase in MTHFR activity in Mthfd1S +/-mice (7.53 + 0.61 nmol × mg protein
) when compared with 
t-test).
The increase in MTHFR activity would explain the increased methylTHF and the absence of changes in levels of methionine and choline metabolites.
MTHFD1-synthetase deficiency reduces the use of one-carbon donors for purine synthesis 10-FormylTHF produced by the MTHFD1 synthetase activity is required for the synthesis of purines; therefore, the relative reduction of formylTHF could reduce purine synthesis and consequently proliferation. To address this hypothesis, we measured the level of radioactive formate incorporation into DNA in cell lines from the two genotype groups. Spontaneously immortalized Mthfd1S +/+ and Mthfd1S +/-mouse embryonic fibroblast (MEF) cell lines (three per group) were cultured in media containing either 14 C-formate or 3-14 C-serine, and 5-3 H-dCTP to control for DNA synthesis. Total DNA was extracted from the cells and the amount of incorporated radiolabel was measured. 14 C counts from total DNA were divided by 3 H counts to normalize for cell growth. Formate incorporation into total DNA was decreased in Mthfd1S +/-cell lines ( Fig. 7 ; P , 0.005, t-test), consistent with reduced production of 10-formylTHF by the synthetase for use in purine synthesis. Incorporation of carbon 3 of serine into DNA was also significantly decreased in Mthfd1S
+/-cells (P , 0.0001, t-test). This reduction demonstrates that carbon 3 of serine is normally incorporated into purines via the mitochondrial SHMT2-MTHFD2/L-MTHFD1L formate pathway in these cell lines, with transfer of mitochondrial formate into the cytoplasm for use in nucleotide synthesis. Furthermore, these results suggest that donation of carbon from serine for nucleotide synthesis via SHMT1 and the MTHFD1 dehydrogenase -cyclohydrolase activities does not compensate for reduced MTHFD1 synthetase activity.
In both Mthfd1S +/+ and Mthfd1S +/-immortalized MEF cell lines, the majority of radiolabelled carbon from serine and formate was found in purines and comparatively little was found in thymidylate (data not shown), as previously observed in Mthfd2
+/+ and Mthfd2 -/-immortalized cell lines (39) .
Although overall incorporation of one-carbon donors into DNA was reduced by synthetase deficiency, the relative proportion of radiolabel from formate and serine into individual bases (purines through 10-formylTHF or thymidylate through 5,10-methyleneTHF) was not affected. These observations suggest that there was no redistribution in the utilization of onecarbon donors toward purine synthesis to compensate for MTHFD1-synthetase deficiency at the expense of thymidylate synthesis.
MTHFD1-synthetase deficiency is associated with reduced white blood cell counts in pregnant females
Since synthetase deficiency is associated with decreased purine synthesis, we questioned whether cellular proliferation could also be affected. We therefore assessed CBCs in E10.5 pregnant females from whole blood collected at sacrifice (n ¼ 10
). The red blood cell count was not significantly affected by genotype (data not shown). However, the white blood cell (WBC) count was reduced by 20% in the heterozygotes (P , 0.05, t-test, Fig. 8 ). When examined by leukocyte type, we observed that the neutrophil count was significantly reduced by 37% (P , 0.05, t-test, Fig. 8 ). The proportion of neutrophils in the leukocyte count was also altered (from 16.6% in Mthfd1S +/+ mothers to 13.4% in Mthfd1S +/-mothers, P , 0.05, t test). The lymphocyte count decreased by only 15% (borderline significant, P ¼ 0.099, t-test, Fig. 8 ). However, there was a small but significant increase in the relative proportion of lymphocytes in the leukocyte count (from 82.2% in wild-type mothers to 85.7% in heterozygous mothers, P , 0.05, t-test).
Neutrophils are short-lived rapidly dividing cells that increase in number dramatically during pregnancy (40) . The decrease in neutrophils suggests that proliferation of rapidly dividing cell types may be limited by MTHFD1-synthetase deficiency during the period of rapid growth characteristic of pregnancy and could contribute to adverse outcomes.
DISCUSSION
Genetic variations in genes of folate metabolism and dietary folate insufficiency have been established as risk factors for adverse reproductive outcomes, cardiovascular disease and cancer. The MTHFD1 p.R653Q variant has been proposed as a risk factor for a variety of birth defects and pregnancy complications, in particular increased NTD risk in the Irish population (12, 16, 17) and increased risk for heart defects in our Canadian study (13) . We have previously shown that MTHFD1 p.R653Q reduces the stability of the formylTHF synthetase domain resulting in 25% lower metabolic activity in cells, without affecting methyleneTHF dehydrogenase activity (13) . Our studies in this novel mouse model are consistent with the in vitro observations because the mice have reduced synthetase activity without an impact on dehydrogenase activity or MTHFD1 expression.
Mthfd1S -/-embryos did not survive past E10.5, demonstrating that MTHFD1-synthetase activity is essential in mice, and is not adequately compensated for by the combined dehydrogenase and cyclohydrolase activities of MTHFD1. Mthfd1S -/-embryos were considerably smaller and developed more slowly than their littermates. In embryos, the combined activities of MTHFD2/2L and MTHFD1L work together to generate formate in the mitochondria; the formate then enters the cytoplasm for use by MTHFD1 to produce one-carbon substituted folates in the cytoplasm (10) . Development of Mthfd1S -/-embryos was particularly affected in areas where MTHFD1, MTHFD2 and MTHFD1L were observed to be highly expressed in whole mount E9.5 -11.5 embryos (specifically the tail, somites and neural tube) (29, 41) . Embryonic lethality of Mthfd1S -/-embryos is likely due to inhibition of cell proliferation due to a lack of purines. MTHFD1 uses mitochondrial formate to make one-carbon substituted folates that are used for purine synthesis (33) or homocysteine remethylation (29) . In rats, MTHFD1 expression was found to correlate with increased demand for nucleotides during organogenesis (42) . De novo purine synthesis is rate-limiting for cell proliferation in Chinese hamster ovary cells (43) . A complete loss of MTHFD1 results in purine auxotrophy in immortalized MEF cell lines (33) . When these cells were stably transfected with wild-type or synthetase-deficient MTHFD1 they were no longer purine auxotrophs, but the proliferation of the synthetasedeficient cells was reduced compared with the wild-type (44) . Reduced formate and serine incorporation into DNA of Mthfd1S +/-MEF cells in this study suggests that synthesis of purines from mitochondrial formate is impaired; our findings are consistent with observations that salvage of purines is insufficient to support embryonic development (31, 45, 46) . The increased methylTHF with decreased DHF and THF in liver is suggestive of a weak methyl trap (47) which might lead to altered activity of other folate-dependent enzymes. It is possible that this disturbance could also contribute to embryonic lethality.
Purine insufficiency may also explain the reduced neutrophil numbers observed in Mthfd1S +/-pregnant females. These WBCs, the most numerous in the innate immune system, are short-lived, constantly regenerating cells that increase in number dramatically during pregnancy. In earlier work, we had shown that the expression of MTHFD1 and PPAT, which catalyses the first committed step of de novo purine synthesis, was higher in female mice than male mice, and had suggested that females might be particularly reliant on one-carbon folate metabolism during reproduction (37) . Neutrophil counts were also decreased in Mthfd1S +/-females that were not pregnant; however, this decrease was not significant (P ¼ 0.126). The increased nutritional requirements of pregnancy may make MTHFD1-synthetase-deficient females unable to meet the demand for formylTHF to synthesize enough purines to sustain rapid cell division. We are not aware of studies that have examined haematopoiesis, particularly during pregnancy, in women with the p.R653Q variant. Our observation in mice also suggests that other rapidly dividing cell types, such as tumour cells, may be affected by synthetase deficiency. Future studies will be useful in examining the effects of reduced synthetase activity on tumour initiation and progression.
MTHFD1-synthetase activity was reduced by 60% in the liver of Mthfd1S +/-mice, without affecting dehydrogenase activity or MTHFD1 expression. As the dehydrogenase and cyclohydrolase activities of MTHFD1 share an active site, it can be assumed that the cyclohydrolase activity is also unaffected. MTHFD1-synthetase deficiency caused an 30% reduction in the incorporation of formate into the DNA of immortalized Mthfd1S +/-cell lines (Fig. 7) . This decrease is comparable with the 26% reduction in formate incorporation we observed in Mthfd1
-/-cells transfected with the MTHFD1 cDNA carrying the p.R653Q polymorphism, in comparison to the wild-type cDNA (13) . The Mthfd1S +/-mouse, therefore, appears to be a good model for individuals that are homozygous for the MTHFD1 p.R653Q variant.
Cytoplasmic SHMT1 does not compensate for MTHFD1-synthetase deficiency since the incorporation of carbon-3 of serine into DNA was also reduced by 40% in Mthfd1S +/-cells. In addition, the distribution of the 14 C label from serine between purines and thymidylate did not differ from the distribution of the 14 C label in the formate incorporation experiments. These findings suggest that the serine is not primarily being used for nucleotide synthesis via SHMT1 and the DC activities of MTHFD1. The majority of 14 C found in the DNA does not seem to come from the donation of carbon-3 of serine to dTMP by thymidylate synthase but rather from the conversion of serine carbon-3 to formate by the mitochondrial pathway (SHMT2, MTHFD2/2L, MTHFD1L) (see Fig. 1 ). This formate then crosses into the cytoplasm for use in purine synthesis via the synthetase activity of MTHFD1. Our findings are consistent with observations that serine, the major carbon donor for one-carbon folate reactions (48, 49) , is metabolized in a distinct manner through the contributions of SHMT1 and SHMT2 to the cytoplasmic and mitochondrial fluxes, respectively, of one-carbon units (reviewed in 10). In contrast to the effects on purine synthesis, the methylation cycle appears to be unaffected by MTHFD1-synthetase deficiency in mice fed a replete diet. The levels of SAM, SAH, methionine and homocysteine in plasma and liver were unchanged in the Mthfd1S +/-mice. The methylation cycle does not appear to be supported by the folate-independent remethylation of homocysteine by BHMT (Fig. 1) , which is often utilized when folate-dependent remethylation is compromised (35, 37) , since the levels of betaine, choline and related metabolites were also unaffected by MTHFD1-synthetase deficiency. These observations were somewhat surprising, as it has been shown that mitochondrial formate makes up the majority of one-carbon units used for homocysteine remethylation in vitro (29) . The observed increase in both MTHFR activity and percentage of methylTHF in the liver of pregnant females suggests that methylTHF production is upregulated to support the methylation cycle at the expense of formylTHF and purine synthesis. In this respect, our mouse model is consistent with the effects of the MTHFD1 p.R653Q SNP: no significant changes in homocysteine have been reported in individuals homozygous for the Q allele (11, 12, 15, 22, 50, 51) . However, the effects of this variant may be influenced by diet as borderline significant increases in homocysteine have been observed in homozygous women on a folate-restricted diet (52) , and women with the Q allele were reported to be more susceptible to organ dysfunction due to a choline-restricted diet (36) . Studies of our mouse model with dietary variation will be relevant in this regard.
We observed that Mthfd1S +/-females were heavier than wildtype females. Although the mechanism behind this observation is unclear, decreased serum folate has been associated with an increased body mass index in clinical studies (53, 54) . Our observation merits additional investigation.
Comparison of the phenotypes of our Mthfd1S mouse with related mouse models reveals that the loss of synthetase activity alone is not as detrimental as loss of the entire trifunctional enzyme MTHFD1 or the loss of MTHFS which delivers 10-formylTHF to the purinosome. The phenotype of Mthfd1 gt/gt and Mthfs gt/gt embryos is more severe than that of Mthfd1S -/-embryos; they do not survive as long, and are completely resorbed by E9.5 (55, 56) . In the Mthfd1 gt/gt mouse, MTHFD1 expression is compromised, effectively knocking out all of the MTHFD1 activities (57) . Loss of all three activities is a much more severe defect than loss of synthetase alone, presumably because the ability to produce methyleneTHF from formylTHF and the alternate pathway to formylTHF synthesis are lost. MTHFS, in addition to delivering 10-formylTHF (produced by MTHFD1) to the purinosome for purine synthesis, also converts 5-formylTHF, a THF storage form, to methenylTHF to re-enter one-carbon folate metabolism (56) . The loss of these functions leads to impaired purine synthesis in vitro and reduced total folate in plasma (56) .
The importance of de novo purine synthesis during embryonic development is underscored by the afore-mentioned mouse models. In contrast to the above lethal phenotypes, mice completely lacking HPRT1, required for purine salvage, are viable and fertile due to increased de novo purine synthesis (58) . This finding confirms that de novo purine synthesis can compensate for loss of purine salvage, but not vice versa.
In contrast to Mthfd1S -/-embryos, Mthfd2 -/-embryos appear to be developmentally normal, although smaller, and die after E12.5 due to failure to establish definitive haematopoiesis (59) . Similarly, Mthfd1L z/z embryos, which lack mitochondrial 10-formylTHF synthetase activity, survive as long as 12.5 days gestation and have turned, but have neural tube anomalies (38) . It is clear from these phenotype differences that the inability to use mitochondrial formate is more detrimental to embryonic development than the inability to produce formate in the mitochondria. It is possible that the inability of the Mthfd1S -/-embryos to use mitochondrial formate might lead to formate accumulation and toxicity that could also contribute to their impaired development.
We observed a maternal Mthfd1S +/-genotype effect on the incidence of birth defects such as turning defects and abnormal craniofacial development. This increase in birth defects probably reflects impaired proliferation of rapidly dividing cells that are not adequately supported by maternal one-carbon metabolism. Embryonic genotype did not have a significant effect on the incidence of birth defects when compared within maternal genotype groups, although our power to detect an embryonic genotype effect may have been limited. It is also possible that embryonic effects may come into play at a later time in development.
Neural tube closure was abnormal in Mthfd1S -/-embryos, although we did not see NTD in embryos of Mthfd1S +/-mice. Perhaps larger numbers of embryos need to be studied given the relative rarity of NTD in human populations. Alternatively, increased NTD risk associated with p.R653Q may be increased by low maternal folate intake (19) , and the association is strongest in Ireland, where there is no folic acid fortification of food. It would be worthwhile to investigate the effect of diet -genotype interactions on pregnancy outcomes, as well as gene -gene interactions, in this mouse model.
In conclusion, we have generated an MTHFD1-synthetasedeficient mouse that is a good experimental model for the evaluation of the biochemical and phenotypic consequences of the R653Q variant in humans. Our findings suggest that maternal synthetase deficiency has an impact during pregnancy on the haematopoietic system and on embryonic development. These observations warrant additional investigations of pregnant women with this common polymorphism.
MATERIALS AND METHODS
Generation of knock-in mice
The targeting vector ( Fig. 2A ) was made using a 5.6kb HindIII fragment of murine 129Sv/J genomic DNA subcloned into pBluescript-SK + that encompassed exons 9 through 15 of Mthfd1 (60). MTHFD1 formylTHF synthetase activity was inactivated by introducing the p.K386E mutation into exon 12 by overlap extension PCR (overlap primers: gK386E-1 5
′ -GATCGTGGTAGTACTCTCCCCTTCTCC-3 ′ and gK386E-2 5 ′ -GGAGAAGGGGAGAGTACTACCACGATC-3 ′ , flanking primers: 5 ′ -GGCTTGATGATTAAGAGCCTAGGCTGC-3 ′ and 5
′ -CCCGAGATTCTCTGCATATGTCAAAAGG-3 ′ ). These primers introduced a ScaI restriction enzyme site adjacent to the p.K386E mutation which was used for identification during mutagenesis. The A to G nucleotide change that substitutes glutamate for lysine removes an EarI site, which was used to genotype mice by restriction fragment length polymorphism (RFLP, see below). The floxed neomycin-resistance thymidine kinase (neo r -TK) cassette of the pflox vector (61) was then blunt-end ligated into the BamHI site adjacent to exon 12. The vector was linearized by digestion with NotI and electroporated into ESR1 cells (62) as in (59) .
Neomycin-resistant ES cell lines were screened for homologous recombination by Southern blot with the 3 ′ end probe (Fig. 2B) as in (59) . Positive cell lines identified in the initial screen were confirmed to be properly targeted by Southern blot using the 5 ′ , 3 ′ (both Fig. 2B ) and neo r cassette (not shown) probes. Presence of the K386E mutation in exon 12 was verified by PCR using primer set 1 (5 ′ -CTGTACAG TGACTTGGGTGACA-3 ′ and 5 ′ -TGTCGCACACATGCAAA GACGTTC-3 ′ ; 948C 30 s, 608C 30 s, 728C 45 s, 35 cycles) followed by EarI digestion (RFLP, Fig. 2C ), and by direct sequencing (not shown). Two cell lines were properly targeted and contained the K386E mutation (AA7 and EH5). The neo r -TK cassette was removed from these cell lines at the Goodman Cancer Centre Transgenic Core Facility (McGill University) via transient transfection of pBS185, a Cre-expressing vector. Recombinant cell lines were screened by PCR with primer set 2 (5 ′ -TTGGCTGTGGGTGAGTAAATGGGT-3 ′ and Figure 8 . Decreased WBC counts in pregnant Mthfd1S +/-females suggest that proliferation of rapidly dividing cells is limited by MTHFD1 synthetase deficiency. (A) WBC count was significantly reduced in heterozygous females sacrificed at E10.5 (n ¼ 10 wild-type, 11 heterozygous, * P , 0.05, t test). (B) Neutrophil count in the heterozygous mothers was reduced by 37% compared with wild-type mothers ( * P , 0.05, t-test). (C) Lymphocyte count decreased by 15% in heterozygous mothers compared with wild-type mothers (w, borderline significant, P ¼ 0.099, t-test). ′ -TTGCACTAGTGGCTGGTGAGAGTT-3 ′ , Fig. 2C ); 2 AA7 and 10 EH5 cell lines were found to be properly recombined by PCR and presence of the K386E mutation verified by RFLP (Fig. 2C) .
Two Cre-recombined cell lines from each parent line were used for injection into E3.5 C57Bl/6 blastocysts at the Goodman Cancer Centre Transgenic Core Facility, McGill University. A total of six chimeras were obtained from the EH5 cell lines and mated with C57Bl/6N mice (Charles River). Tail DNA of progeny was genotyped by RFLP. Germline transmission was established from two chimeras from separate Cre-recombinant cell lines (EH5 B5 and EH5 D1). Proper targeting and recombination in parent cell line DNA and tail DNA of founder mice were verified by Southern blot (Fig. 2B) .
Mice used for experiments were backcrossed with C57Bl/6N for 5 generations (N5), unless noted (alternating male and female wild-type), and therefore can be assumed to be at least 98% congenic with this genetic background. All mice used in this study had Mthfd1S
+/+ mothers and Mthfd1S +/-fathers, unless noted. The mice were fed standard commercially available laboratory chow (diet 2019, Harlan Teklad), and exposed to a 12 h lightdark cycle. All procedures and experiments were performed within the guidelines of the Canadian Council on Animal Care and approved by the Animal Care Committee of the Montreal Children's Hospital and the McGill University Research and Ethics Animal committee.
Genotyping of Mthfd1S-deficient mice and embryos
Tail DNA was genotyped using primer set 1 followed by EarI digestion as described above. Embryos were genotyped via yolk sac or total embryo DNA using a Lightcycler LC480 (Roche Diagnostics) by either end point genotyping (hydrolysis probes, Sigma-Aldrich) or melting curve analysis (hybridization probes, TIB MolBiol) using Probes MasterMix (Roche Diagnostics). Primers, probes and conditions are as follows. 
Tissue collection
Mice were sacrificed by asphyxiation and body weight recorded. Blood was collected by cardiac puncture in potassium-EDTA tubes. Whole blood was collected for complete blood cell counts (Animal Resource Center, McGill University); plasma was separated by centrifugation at 3000g for 7 min. Tissues were collected, weighed, rinsed with cold phosphate-buffered saline and snap frozen on dry ice. Tissues and plasma were stored at 2758C or below.
Enzyme assays
Protein extracts were prepared from 50 mg frozen liver by homogenizing by Polytron in extraction buffer containing 100 mM phosphate pH 7.3, 35 mM b-mercaptoethanol and 1× EDTA-free complete-mini protease inhibitor (Roche Diagnostics) and cleared by centrifugation. Glycerol was added to 20% (v/v) as a stabilizer. The protein content was determined by Bradford assay in triplicate with bovine serum albumin standard (63). 5,10-MethyleneTHF dehydrogenase and 10-formylTHF synthetase assays were performed as in (13); results are expressed as the average + standard deviation of triplicate determinations. MTHFR assays were performed in duplicate as described (64) .
Western blotting
Protein extracts were prepared from 25 mg frozen liver by homogenizing by Tissuelyser (Qiagen) in RIPA buffer containing 1× complete-mini protease inhibitor (Roche Diagnostics) and cleared by centrifugation. Western blotting was performed as in (37) , using MTHFD1 (65) and GAPDH (Cell Signalling Technology) primary antibodies with a horseradish peroxidaseconjugated donkey anti-rabbit IgG secondary antibody (GE Healthcare Bio-Sciences). Proteins were quantified from film exposures by densitometry using Quantity One 4.1.0 (Bio-Rad Laboratories).
Metabolite measurements
Plasma and liver folates Concentrations of folate derivatives (5,10-methyleneTHF + THF, 5-methylTHF, 10-formylTHF, DHF + folic acid, and total folates) in frozen plasma from 8-week-old males were measured by a ternary complex assay (66). 5-MethylTHF in frozen plasma from pregnant female mice was determined by LC-ESI-MS/MS. Fifty microliters of the sample were combined with 10 ml of 62.5mM dithiothreitol, 20 mg/ml ascorbic acid and 2.5 mM 13 C 5 -5-methylTHF and incubated for 10 min at room temperature in the dark. Samples were deproteinized with five volumes of acetonitrile containing 5 mg/ml of ascorbic acid, vortexed and centrifuged at 14 800 rpm for 10 min. Twenty microliters of cleared extract were injected on a Synergi Hydro 4 m 150 × 3 mm maintained at 308C (Phenomenex) and eluted at 0.5 ml/min with a stepwise gradient of buffer A (100% water with 0.1% formic acid) and buffer B (100% methanol with 0.1% formic acid): 0.0-5.5 min, 5% B; 5.6 min, 50% B (linear gradient 2); 7.5 min, 75% B (linear gradient); 7.6 min, 5% B (linear gradient); total run time 10 min. The observed (m/z) values of the fragment ions were 5-methylTHF (m/z 460 313) and 13 C 5 5-methylTHF (m/z 465 313). Data were collected and processed using Analyst software version 1.4.2 (Applied Biosystems).
Folate distribution (DHF, THF, methenylTHF, methyleneTHF, methylTHF, formylTHF) in frozen liver from female mice was determined by LC-ESI-MS/MS. Tissue was homogenized in buffer containing 20 mM ammonium acetate, 0.1% ascorbic acid, 0.1% citric acid and 100 mM DTT at pH 7.0 using a dounce homogenizer followed by sonication for 10 s using a hand-held sonicator at 40% amplitude. Protein was removed by precipitation by addition of two sample volumes of acetonitrile, mixing for 2 min and centrifugation for 15 min at 12 000 and 48C. Supernatants were transferred to fresh tubes, lyophilized and stored at 2808C prior to analysis. Lyophilized samples were resuspended in 50 ml 2 mM ammonium acetate, 0.01% ascorbic acid, 0.01% citric acid and10 mM DTT at pH 7.0 and centrifuged for 5 min at 12 000 g at 48C. Supernatants were transferred to glass sample vials for LC-MS/MS analysis. Metabolites were resolved by reversed-phase chromatography (Luna C18 column; 150 mm × 2.0 mm; 5 mm bead size; Phenomenex, UK) using a 2795XE high-performance liquid chromatography unit with solvent divert valve (Waters Corporation, UK) coupled to a MicroMass Quattro triple quadrupole tandem mass spectrometer (Waters Corporation, UK) operating in negative-ion mode, as described previously (67) . Folates were measured by multiple reaction monitoring with optimized cone voltage and collision energy for precursor and product ions adapted from (68) .
Plasma and liver methionine metabolites
Plasma total homocysteine and methionine were determined by LC-ESI-MS/MS as previously described (69) . SAM, SAH, methionine, cystathionine, choline and betaine in plasma and liver tissues were determined by LC-ESI-MS/MS as previously described (70) . Liver tissue was deproteinized with 10 volumes of 0.4 M perchloric acid (PCA). To 20 ml of plasma or liver PCA extract, 100 ml (plasma) or 180 mL (liver) of mobile phase A was added containing 10-50 mmol/l of each internal standard. Prepared samples were filtered through microcentrifugal filter units (Amicon Ultra-0.5 ml, 10 kDa NMWL, Millipore, USA). Filtered plasma and liver extracts were loaded into 96-well microtiter plates and 5 ml injected for analysis. All data were collected and processed using Analyst software version 1.4.2 (Applied Biosystems).
Hepatic choline metabolites
Levels of choline metabolites in frozen liver were measured by LC-MS. Choline, DMG and betaine were determined using the method given in (71) . Choline, betaine, GPC, phosphocholine, phosphatidylcholine, sphingomyelin, and lysophosphatidylcholine were measured using the method in (72), with modifications (73, 74) .
Timed matings
Nulliparous 10-to 20-week-old Mthfd1S +/+ and Mthfd1S +/-females were mated with Mthfd1S +/-males; the day that a vaginal plug was observed was designated E0.5 as in (75) . At E10.5, the mother was sacrificed and embryos collected, measured and assessed for developmental delays and morphological anomalies. Maternal tissues and plasma were collected as described above. The number of eggs released, implantation sites and embryonic losses (necrotic implantation sites and sites lacking embryos) were recorded as in (76) . The rate of embryonic loss was calculated as the number of resorptions divided by number of implants per litter. Embryonic crown-rump length and somite number were determined. Null embryos and those damaged during dissection were excluded from the analysis of crown-rump length and somite number.
Embryos were examined for gross morphological defects and delay and photographed using a Leica stereomicroscope and Leica Application Suite image capture software. Embryos were considered to be E10.5 if they had complete closure of posterior neuropore, presence of hindlimb and tail buds, lens plate, pointed shape of otic vesicle and 34 -40 somites (77) . Embryos were considered delayed if they were one day or more delayed in development (lacking hindlimb and tail buds, lack of invagination of the optic vesicle, round otic vesicle, ,34 somites). Following examination, embryos were either fixed in 4% paraformaldehyde overnight and transferred to 70% ethanol for storage or frozen at less than 2758C.
At E7.5 and 8.5, the mother was sacrificed and the embryos collected and examined for gross morphological defects and delay. Embryos were considered to be typical E7.5 if they had a primitive streak which extended at least 100% of the length of the embryonic portion of the posterior pole, a distinguishable node, an amniotic cavity and an extraembryonic coelom under the dissecting scope. Normal E8.5 embryos ranged from the late head fold stage embryos with sigmoid-shaped headfolds and a fully extended allantois and no somites to embryos with 4-12 pairs of somites, a beating heart, neural tube closure at the level of the hindbrain and chorioallantoic attachment.
Establishment of spontaneously immortalized Mthfd1S
1/1
and Mthfd1S 1/-cell lines
Mouse embryonic fibroblast cell lines were established by trypsinizing individual E9.5 -12.5 embryos derived from heterozygous crosses and immortalized by serial passage in culture as in (78) . Cells were cultured in DMEM containing 12.5% heat-inactivated fetal bovine serum (Wisent), 1× penicillinstreptomycin, 1× non-essential amino acids, 50 mg/ml gentamicin (Wisent), 0.5 mg/ml fungizone, 30 mM thymidine (Sigma Aldrich) and 30 mM hypoxanthine (Sigma Aldrich). Cells for labelling experiments were gradually adapted to minimal essential medium (Invitrogen catalog #10370) containing 15% dialysed heat-inactivated FBS, 1× glutamine, 1× penicillin -streptomycin and 30 mM hypoxanthine. Cell culture reagents were obtained from Invitrogen, unless noted. It was not possible to establish cell lines from Mthfd1S -/-embryos (attempted from nine litters at E9.5-10.5). The practical lower limit for establishing cell lines from embryos is E8.5 (78) . Null embryos at E10.5 are growth delayed compared with normal E8.5 embryos and are not viable beyond this time point. The impact of MTHFD1-synthetase deficiency on the incorporation of one-carbon units from formate and serine into DNA was performed as in (39) with modifications. 7 × 10 4 cells/well were plated in six-well plates in minimal essential medium containing 15% dialysed fetal bovine serum and 1× glutamine and allowed to grow overnight to 80% confluency. Cells were labelled for 24 h with 6 × 10 6 dpm [ 14 C]formate or 2 × 10 6 dpm L- [3- 14 C]serine, with 3 × 10 6 dpm [5-Radiolabled Chemicals Inc.) as a control for DNA synthesis as in (13) . After labelling, cells were collected and frozen as in (13 To assess one-carbon donor incorporation into individual bases, DNA obtained as above was hydrolysed and individual DNA bases separated by ascending paper chromatography as in (39) . Experiments were performed in pairs of Mthfd1S +/+ and Mthfd1S +/-cell lines in triplicate per cell line per one-carbon donor.
Statistical methods
Enzyme assay, western blot and cell culture radiotracer results are expressed as mean + standard deviation. Metabolite level results are expressed as mean + standard error (SEM). Mean values were compared by the independent samples t-test between the two genotype groups with correction for unequal variances where required.
Genotype distributions were analysed using the chi-square test. For analysis of effects of genotype on pregnancy outcomes and embryonic development, the litter or female was considered as the unit for statistical analysis. Results are expressed as the mean + SEM. Comparisons of means were performed using independent samples t-tests, with correction for unequal variances where required. Genotype effects on embryonic delay and defects were assessed using two-tailed Fisher's exact test (for n) and t-test (for %/litter); null embryos were excluded from this analysis.
Statistical analyses were performed using SPSS Statistics Version 20 (IBM), and GraphPad Prism 5.02 (GraphPad Software, Inc.). P ≤ 0.05 were considered significant.
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